Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00399555 · ClinicalTrials.gov registry record

Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome

A clinical trial of Congenital Heart Disease, sponsored by Emory University.

Completed
Registry status
28
Enrollment target
1
Study location

NCT00399555 is a study of Congenital Heart Disease that has completed, run by Emory University. The registered enrollment target is 28 participants, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00399555, a study of Congenital Heart Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
28 participants
Enrollment target
1
Study location

Study Summary

There have been many improvements in the care of children with hypoplastic left heart syndrome (HLHS). This has helped these children survive longer. Because these children now live longer, researchers are recognizing developmental disabilities (the children are behind in their thinking or physical activity) in children with hypoplastic left heart syndrome. The purpose of this research study is to help the investigators learn more about developmental disabilities in children with hypoplastic left heart syndrome. During the time of your child's first surgery for hypoplastic left heart syndrome, a monitor was placed on your child's forehead to measure the oxygen levels in the brain. This monitor is called Near Infrared Spectrometry (NIRS). The researchers involved in this study want to know if oxygen levels in the blood vessels of the brain have any effect on developmental disabilities later in life in children with hypoplastic left heart syndrome. The researchers plan to enroll 60 research subjects.

Conditions Studied

Study Locations (1)

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2006-11
Est. Completion 2009-07

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT00399555

The ClinicalTrials.gov registry entry for NCT00399555 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00399555 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00399555 about?

NCT00399555 is a clinical study titled "Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome". There have been many improvements in the care of children with hypoplastic left heart syndrome (HLHS). This has helped these children survive longer. Because these children now live longer, researchers are recognizing developmental disabilities (the children are behind in their thinking or physical ...

What is the current status of trial NCT00399555?

This trial is currently completed. The enrollment target is 28 participants. The study started on 2006-11. Estimated completion is 2009-07.

What conditions does trial NCT00399555 study?

This clinical trial studies the following conditions: Congenital Heart Disease.

Who is sponsoring clinical trial NCT00399555?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00399555 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.